Related Experiment Video
Updated: May 15, 2026

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
Published on: October 2, 2014
H2S induces apoptosis of tumors with high IDO1 expression via NR4A1-BCL-2 and SOCS3 pathways
Zhen Ning Tony He1, Fangzhou Meng1, Xiaoyang Qian1
1State Key Laboratory of Genetics and Development of Complex Phenotypes, School of Life Sciences, MOE Engineering Research Center of Gene Technology, Shanghai Engineering Research Center of Industrial Microorganisms, Fudan University, Songhu Road 2005, Shanghai, 200438, China.
Background:
Hydrogen sulfide (H2S) has been reported to exert both protumor and antitumor functions. It is worthy to clarify the condition under which H2S exerts antitumor effects and its underlying mechanism. Our previous study connected the immune checkpoint indoleamine 2,3-dioxygenase 1 (IDO1) and H2S by revealing that H2S downregulates IDO1 expression, leading to our hypothesis that antitumor effect of H2S is associated with IDO1 expression in tumor cells.
Methods:
Apoptosis, cellular distribution of NR4A1, phosphorylation of IDO1, and the binding of phosphorylated IDO1 and SOCS3 are examined both in vitro and in vivo.
Results:
In this study, we confirm our hypothesis by showing that H2S significantly reduces proliferation and induces apoptosis of tumor cells with high IDO1 expression. In tumor cells with high IDO1 expression, H2S promotes the translocation of NR4A1 out of nucleus and its binding with BCL-2, as well as the phosphorylation of IDO1 and the codegradation of phosphorylated IDO1 and SOCS3. Such mechanism by which H2S induces apoptosis of tumors with high IDO1 expression is also elucidated in tumor-bearing mice, where H2S shows great therapeutic effect against tumors with high IDO1 expression.
Conclusions:
H2S induces apoptosis of tumor cells with high expression of IDO1 by promoting NR4A1-BCL-2 apoptotic pathway and the codegradation of phosphorylated IDO1 and SOCS3. Our study provides new theoretical and experimental evidence for a strategy for tumor therapy with H2S.
Insights
Hydrogen sulfide (H2S) demonstrates antitumor effects by inducing apoptosis in tumor cells with high indoleamine 2,3-dioxygenase 1 (IDO1) expression. This occurs through the NR4A1-BCL-2 pathway and IDO1/SOCS3 codegradation, offering a novel cancer therapy strategy.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Hydrogen sulfide (H2S) exhibits dual roles in cancer, acting as both a protumor and antitumor agent.
- Clarifying the conditions and mechanisms underlying H2S's antitumor effects is crucial for therapeutic development.
- Previous research linked H2S to the immune checkpoint indoleamine 2,3-dioxygenase 1 (IDO1), suggesting H2S downregulates IDO1.
Purpose of the Study:
- To investigate the antitumor effects of H2S in relation to IDO1 expression in tumor cells.
- To elucidate the molecular mechanisms by which H2S induces apoptosis in IDO1-expressing tumors.
- To evaluate the therapeutic potential of H2S against IDO1-high tumors in vivo.
Main Methods:
- Assessing apoptosis and cellular distribution of NR4A1.
- Examining IDO1 phosphorylation and its binding with SOCS3.
- In vitro and in vivo experiments in tumor cell lines and tumor-bearing mice.
Main Results:
- H2S significantly reduces proliferation and induces apoptosis in tumor cells with high IDO1 expression.
- H2S promotes NR4A1 nuclear export and binding with BCL-2, alongside IDO1 phosphorylation.
- Tumor-bearing mice treated with H2S exhibited significant therapeutic effects against IDO1-high tumors.
Conclusions:
- H2S induces tumor cell apoptosis via the NR4A1-BCL-2 pathway and promotes the codegradation of phosphorylated IDO1 and SOCS3.
- This study provides novel theoretical and experimental evidence supporting H2S as a potential cancer therapeutic agent.
- The findings highlight the importance of IDO1 expression levels in determining H2S's efficacy.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
The Extrinsic Apoptotic Pathway
Apoptosis
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
